SeaStar Medical is trading at $2.52, down -11.40%, with no confirmed company-specific explanation for the October 23 decline.
- Positive pediatric registry findings were reported October 22, but do not establish a cause for the decline.
- Healthcare stocks are down 1.29%. Uncertainty following Quest Diagnostics’ cyberattack disclosure may add sector pressure, but available evidence does not confirm it explains SeaStar Medical’s sharper decline.